In 2012, about 2 million people died from diseases which could have been prevented by vaccination. The Disability Adjusted Life Year (DALY) in India, for the year 2012, was 39,496 years, where DALY is the number of years lost due to poor health, disability and early deaths. For the year, India’s mortality count stood at 1,800. The major segments of the Indian vaccine market are Universal Immunization Program++ (UIP++), post-incident vaccines, emerging mandatory vaccines, regular optional vaccines, one-time optional vaccines and pulse polio vaccines. With a Compound Growth rate (CAGR) of 20 percent through 2013-2018, the projected revenue is expected to be USD 1193.83 million by 2018.

1. Disclaimer: All information contained in this report has been obtained from sources believed to be accurate by Gyan Research and Analytics (Gyan). While
reasonable care has been taken in its preparation, Gyan makes no representation or warranty, express or implied, as to the accuracy, timeliness or
completeness of any such information. The information contained herein may be changed without notice. All information should be considered solely as
statements of opinion and Gyan will not be liable for any loss incurred by users from any use of the publication or contents.
Vaccine Market in
India: 2009-2018

2. Vaccine Market in India (2009-2018)
2 | P a g e
© Gyan Research and Analytics Pvt. Ltd., 2015
Table of Contents
1. Market Size - India
1.1 Major Players
1.2 Top Vaccines
2. Market Segmentation
3. Regulatory Policies
4. Major Trends
4.1 Bio-pharmaceuticals
4.2 Research & Development (R&D)
4.3 Combination Vaccines
4.4 Veterinary Vaccines
4.5 New Vaccines
5. Challenges and Issues
5.1 Supply Chain
5.2 Quality and Intellectual Property Protection
5.3 Clinical Trials
5.4 Poultry Vaccination Segment
6. Outlook

3. Vaccine Market in India (2009-2018)
3 | P a g e
© Gyan Research and Analytics Pvt. Ltd., 2015
Synopsis
In 2012, about 2 million people died from diseases which could have been prevented by vaccination.
The Disability Adjusted Life Year (DALY) in India, for the year 2012, was 39,496 years, where DALY is
the number of years lost due to poor health, disability and early deaths. For the year, India’s
mortality count stood at 1,800. The major segments of the Indian vaccine market are Universal
Immunization Program++ (UIP++), post-incident vaccines, emerging mandatory vaccines, regular
optional vaccines, one-time optional vaccines and pulse polio vaccines. With a Compound Annual
Growth rate (CAGR) of 20 percent through 2013-2018, the projected revenue is expected to be USD
1193.83 million by 2018.
In 2012, the share of bio-pharmaceuticals in the biotechnology market was 64 percent. High export
value of bio-pharmaceutical products and an increase of 5 percent in sales per annum in 2012 can be
attributed to its dominant share among the biotechnology segments. Health consciousness across
the globe has had its impact on India as well, resulting in strong sales of vaccines. In addition,
existing vaccines have lowered the rate of infectious diseases to some extent, leading to customer
buy-ins.
In 2011, there were 26 R&D institutions in India which were working towards bringing in new
vaccines in the market. In 2014, the Indian government announced the introduction of vaccines to
fight rotavirus, rubella, polio and Japanese encephalitis. This can save at least 100,000 infants from
these diseases. However, it is necessary to address certain constraints. These are issues relating to
the distribution of products, maintenance of high quality, long time frame of clinical trials and poor
vaccination system in Indian poultry. India’s under-penetrated vaccine market can achieve a high
growth trajectory if efforts are made by the government and institutions to streamline vaccine
development in the country.

4. Vaccine Market in India (2009-2018)
4 | P a g e
© Gyan Research and Analytics Pvt. Ltd., 2015
GYAN RESEARCH AND ANALYTICS PVT. LTD.
Corporate Office:
LG 37-38, Ansal Fortune
Arcade, Sector-18,
Noida- 201 301
Delhi NCR, INDIA
Phone: +91-120-4235181
Regd. Office:
298-A, Pocket 2
Mayur Vihar Phase -1
Delhi 110 091, INDIA
Central Delivery Centre:
BD-9, Sector-1,
Salt Lake City
Kolkata- 700 064, INDIA
Phone: +91-33-40060084
E-mail: reports@gyananalytics.com
Website: www.gyananalytics.com